🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the long-term safety and the clini...
Status
Recruiting
Location
University of California LA
Start Date
2024-08-13
Trial ID
NCT06401356
Treatments Being Tested
The purpose of this study is to assess the effect of multiple doses of phen...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-27
Trial ID
NCT07783503
Treatments Being Tested
This Phase 1b, multicenter, open-label study aims to evaluate the safety, p...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-04-15
Trial ID
NCT07340138
Treatments Being Tested
The purpose of this trial is to evaluate whether treatment with pelabresib ...
Status
Recruiting
Location
Yale University School Of Medicine
Start Date
2026-06-08
Trial ID
NCT07357727
Treatments Being Tested
A Phase 3, randomized, blinded study comparing pelabresib (CPI-0610) and ru...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2021-04-09
Trial ID
NCT04603495
Treatments Being Tested
Phase 1 2-part study to evaluate the effect of food on pharmacokinetics of ...
Status
Completed
Location
Gabrail Cancer Center Research
Start Date
2021-07-20
Trial ID
NCT05391022
Treatments Being Tested
Phase 1 Part: This was an open-label, sequential dose escalation study of p...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2014-07-16
Trial ID
NCT02158858
Treatments Being Tested
The primary purpose of this study is to evaluate the impact of hepatic func...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-04-24
Trial ID
NCT07422610
Treatments Being Tested
This drug-drug interaction (DDI) study aims to evaluate the impact of pelab...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-06-12
Trial ID
NCT07340190
Treatments Being Tested